OncLive® to Focus on Hematologic
Malignancies in Upcoming State of the Science Summit™

The event will feature guest speakers from Levine Cancer Institute

April 18, 2018 10:32 AM Eastern Daylight Time

CRANBURY, N.J.--(EON: Enhanced Online News)--OncLive®, the leading digital provider of resources and
information for oncology professionals, will presents its latest State
of the Science Summit™ on hematologic malignancies on April
25 at Fairfield Inn and Suites by Marriott Charlotte Uptown in
Charlotte, North Carolina. The event will be chaired by Saad Zafar
Usmani, M.D., chief of Plasma Cell Disorders Program and Director of
Clinical Research in Hematologic Malignancies, Atrium Health, Levine
Cancer Institute.

This educational event is designed to share the latest science and novel
treatment approaches with surgical and medical oncologists. Leading
researchers and practitioners from the field of hematology-oncology will
discuss topics that include treatment of newly diagnosed multiple
myeloma, treatment of early relapse, immunotherapy for B-cell
malignancies and treatment of Hodgkin Lymphoma. The event also includes
two peer exchange panel discussions and a networking reception.

State of the Science Summit™ is a premier conference series
hosted by OncLive® that features medical professionals from
across the nation. To discuss current treatment options, each summit
brings together academic and community-based physicians and health care
professionals from across key disciplines that range from medical and
surgical oncology to hematology.

A digital platform of resources for practicing oncologists, OncLive®
offers oncology professionals information they can use to help provide
the best patient care. OncLive.com is the official website for MJH
Associates’ Oncology Specialty Group, which publishes OncologyLive®,
Oncology Nursing News® and more. MJH Associates is a
full-service health care communications company offering education,
research and medical media, including curetoday.com and CURE®
magazine, the largest U.S. consumer publication focused entirely on
cancer. Combining science and humanity to make cancer understandable,
CURE® reaches patients, cancer centers and advocacy groups.